Literature DB >> 32156179

Update on extracorporeal carbon dioxide removal: a comprehensive review on principles, indications, efficiency, and complications.

Thomas Staudinger1.   

Abstract

TECHNOLOGY: Extracorporeal carbon dioxide removal means the removal of carbon dioxide from the blood across a gas exchange membrane without substantially improving oxygenation. Carbon dioxide removal is possible with substantially less extracorporeal blood flow than needed for oxygenation. Techniques for extracorporeal carbon dioxide removal include (1) pumpless arterio-venous circuits, (2) low-flow venovenous circuits based on the technology of continuous renal replacement therapy, and (3) venovenous circuits based on extracorporeal membrane oxygenation technology. INDICATIONS: Extracorporeal carbon dioxide removal has been shown to enable more protective ventilation in acute respiratory distress syndrome patients, even beyond the so-called "protective" level. Although experimental data suggest a benefit on ventilator induced lung injury, no hard clinical evidence with respect to improved outcome exists. In addition, extracorporeal carbon dioxide removal is a tool to avoid intubation and mechanical ventilation in patients with acute exacerbated chronic obstructive pulmonary disease failing non-invasive ventilation. This concept has been shown to be effective in 56-90% of patients. Extracorporeal carbon dioxide removal has also been used in ventilated patients with hypercapnic respiratory failure to correct acidosis, unload respiratory muscle burden, and facilitate weaning. In patients suffering from terminal fibrosis awaiting lung transplantation, extracorporeal carbon dioxide removal is able to correct acidosis and enable spontaneous breathing during bridging. Keeping these patients awake, ambulatory, and breathing spontaneously is associated with favorable outcome. COMPLICATIONS: Complications of extracorporeal carbon dioxide removal are mostly associated with vascular access and deranged hemostasis leading to bleeding. Although the spectrum of complications may differ, no technology offers advantages with respect to rate and severity of complications. So called "high-extraction systems" working with higher blood flows and larger membranes may be more effective with respect to clinical goals.

Entities:  

Keywords:  acute respiratory distress syndrome; carbon dioxide removal; chronic obstructive pulmonary disease; complications; efficiency; extracorporeal carbon dioxide removal

Mesh:

Substances:

Year:  2020        PMID: 32156179     DOI: 10.1177/0267659120906048

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  3 in total

Review 1.  Extracorporeal carbon dioxide removal for acute respiratory failure: a review of potential indications, clinical practice and open research questions.

Authors:  Alain Combes; Daniel Brodie; Nadia Aissaoui; Thomas Bein; Gilles Capellier; Heidi J Dalton; Jean-Luc Diehl; Stefan Kluge; Daniel F McAuley; Matthieu Schmidt; Arthur S Slutsky; Samir Jaber
Journal:  Intensive Care Med       Date:  2022-08-09       Impact factor: 41.787

2.  Extracorporeal CO2 reduction for COVID-19: hypercapnic respiratory failure post extracorporeal membrane oxygenation.

Authors:  John J Taxiera; Gaetano Cambria; Emily Mackay
Journal:  BMJ Case Rep       Date:  2022-02-25

3.  A bi-centric experience of extracorporeal carbon dioxide removal (ECCO2 R) for acute hypercapnic respiratory failure following allogeneic hematopoietic stem cell transplantation.

Authors:  Philipp Wohlfarth; Peter Schellongowski; Thomas Staudinger; Werner Rabitsch; Alexander Hermann; Nina Buchtele; Amin T Turki; Asterios Tzalavras; Tobias Liebregts
Journal:  Artif Organs       Date:  2021-05-04       Impact factor: 3.094

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.